secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001493152-25-000281
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell postpones AGM to Feb 5, 2025 due to Canada Post disruption
-------------------------------------------------------------------

- AGM rescheduled from Jan 23 to Feb 5, 2025 at 9:00 a.m. ET in Toronto.
- Record date of Dec 9, 2024 unchanged; proxy deadline Feb 3, 2025.
- Postponement due to Canada Post mail disruption for extra proxy solicitation time.
- ISS recommends shareholders vote FOR management proposals per proxy statement.
- Votes already cast remain valid; shareholders urged to vote if not yet done.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225000281/0001493152-25-000281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225000281/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-000281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer